Innocan Pharma Corp. buy Bobysh
Start price
24.03.24
/
50%
€0.20
Target price
24.03.25
€0.80
Performance (%)
-22.11%
Price
26.09.24
€0.16
Summary
This prediction is currently active. The price of Innocan Pharma Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.11%. This prediction currently runs until 24.03.25. The prediction end date can be changed by Bobysh at any time. Bobysh has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Innocan Pharma Corp. | - | - |
iShares Core DAX® | 0.936% | 1.535% |
iShares Nasdaq 100 | 3.064% | 1.968% |
iShares Nikkei 225® | 1.898% | -0.295% |
iShares S&P 500 | 1.653% | 2.318% |
According to Bobysh what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Bobysh for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy mit Kursziel 0,8
Stopped prediction by Bobysh for Innocan Pharma Corp.
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.20
13.12.22
13.12.22
€1.30
13.12.23
13.12.23
9.03%
14.12.23
14.12.23
Could be very worthwhile Investment >20% year
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.39
25.07.22
25.07.22
-
25.08.22
25.08.22
-2.21%
26.08.22
26.08.22
Could be very worthwhile Investment >20% year
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.36
17.05.21
17.05.21
€0.80
17.05.22
17.05.22
26.23%
18.01.22
18.01.22
Could be very worthwhile Investment >20% year